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BRIEF COMMUNICATIONS: CLINICALDrug-eluting stents significantly modify and often compli-
cate the natural history of coronary artery disease. This
report emphasizes that every patient with multivessel
coronary artery disease must be reviewed by a surgeon
and properly informed before stenting.
CLINICAL SUMMARY
A 60-year-old man was transferred to the Sir Charles
Gairdner Hospital with unstable angina. His comorbidities
were obesity (body mass index 33.6 kg/m2), hypertension,
type II diabetes mellitus requiring insulin, hypercholesterol-
emia, and chronic renal failure (creatinine 150 mmol/L) due
to diabetic nephropathy. The patient was an ex-smoker. Left
ventricular ejection fraction was 45% with hypokinesis
of the inferolateral wall. He had severely diseased left
anterior descending (LAD) and left circumflex (LCx) coro-
nary arteries with multiple in-stent stenoses (Figure 1) and
a small nondominant right coronary artery.
The patient had been previously managed elsewhere. In
March of 2002, he was admitted with unstable angina and
underwent percutaneous transluminal coronary angioplasty
(PTCA) of the obtuse marginal (OM) branch. During angio-
plasty, the OM branch was dissected. A 2.5-mm Tsunami
stent (Terumo Corporation, Tokyo, Japan) and a 2.5-mm
Pixel stent (Guidant, Santa Clara, Calif) were placed to over-
lap the area of dissection. In October of 2002, unstable an-
gina and in-stent stenosis of the OM developed, which
were managed by PTCA alone. In May of 2003, unstable an-
gina recurred. The patient underwent repeat PTCA to the
LAD and LCx arteries, during which 3 Cypher stents (Cor-
dis Corporation, Warren, NJ) were placed in the proximal
LAD occluding the second diagonal branch and 4 Zeta stents
(Abbott Laboratories, Abbott Park, Ill) were placed in the
LCx. In January of 2007, the patient presented with unstable
angina, inferolateral myocardial infarction, and pulmonary
edema. The in-stent stenosis in the distal LCx was demon-
strated, and the flow was restored with 4 Cypher stents. In
March of 2007, he presented again with a prolonged episode
of angina and inferolateral infarction and was found to have
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peat PTCA with 2 Cypher stents placed in the LAD and dis-
tal LCx. Unstable angina recurred in 1 week. The patient was
transferred to the Sir Charles Gairdner Hospital and seen by
a cardiothoracic surgeon for the first time.
On admission, the patient continued to have unstable an-
gina at rest despite receiving aspirin, clopidogrel, and hepa-
rin infusion. An intraaortic balloon pump was inserted.
Levosimendan infusion was started, and the patient under-
went urgent coronary artery bypass surgery with a standard
cardiopulmonary bypass. The left internal thoracic artery
was anastomosed to the LAD. A sequential saphenous
vein graft was anastomosed to the first and second diagonal
branches. An individual saphenous vein graft was anasto-
mosed to the OM. The terminal branch was completely oblit-
erated and not graftable. At 3 month of follow-up, the patient
was doing well and free of angina.
DISCUSSION
During a 5-year period, the patient received 15 stents
and 6 coronary angiograms, was admitted to the hospital
7 times with unstable angina, and had 2 myocardial infarc-
tions that resulted in a significant decrease in left ventric-
ular function. The patient apparently did not want
surgery. Yet, the fact is that the patient was not given an
opportunity to see a cardiothoracic surgeon. Could any pa-
tient be properly informed about surgery without seeing
a surgeon? It is likely that most patients undergoing coro-
nary angioplasty are not properly informed of the risk and
benefits of surgery.1-3
At present, for patients with multivessel disease, coronary
artery bypass grafting is associated with lower mortality and
lower rates ofmyocardial infarction and repeat revasculariza-
tion.4,5 Currently, the real controversy is not whether surgery
or stenting should be performed in a diabetic patient with
multivessel coronary artery disease, but rather why patients
with symptoms and anatomy known to benefit from surgery
are still subjected to percutaneous coronary interventions.2,3
To properly describe this iatrogenic course of coronary artery
disease, we coined the term ‘‘coronary stent disease.’’ It
seems that coronary stent disease may affect both patients
and cardiologists. Both may require urgent surgical inter-
vention.
CONCLUSIONS
We believe that every patient with multivessel coronary
artery disease must be treated by a multidisciplinary team
that includes a cardiothoracic surgeon. This must become
a standard of care. Primum non nocere!urgery c April 2009
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FIGURE 1. Multiple stents in the LAD, OM, and terminal branches of the LCx coronary artery (A), with significant in-stent stenosis in the LAD and com-
plete in-stent occlusion of the OM and terminal branches (B).Pneumothorax in two siblings: Is there a genetic basis for recurrence?
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The incidence of primary pneumothorax is reported as 18 to
28 per 100,000 per year for men and 1.2 to 6 per 100,000 per
year for women, with approximately 10% having a positive
family history.1 Although recurrent pneumothoraces on the
ipsilateral side is seen in less than 5% of cases and may
be dependent on the surgical technique, contralateral recur-
rence may arise because of individual or familial predis-
position. Autosomal dominant inheritance of recurrent
pneumothorax within families has been associated with the
mutation of the folliculin (FLCN) gene.2 Patients who
have blebs, bullae, and recurrent pneumothorax with or
without a family history may have mutations in this gene.3
We describe 2 siblings who had multiple ipsilateral and con-
tralateral recurrences despite adequate surgical treatment. In
this family, no mutations in the FLCN gene were found.
CLINICAL SUMMARY
Patient 1
A 14-year-old girl presented with a small left-sided pneu-
mothorax that was successfully treated with needle aspiration.
She returned 2months later with ipsilateral recurrence and un-
derwent video-assisted thoracoscopic surgery. A left upper
third pleurectomy and apicectomy were carried out. Two
weeks later, a contralateral right-sided pneumothorax devel-
oped, and she underwent right video-assisted thoracoscopic
surgery, apicectomy, and pleurectomy. A recurrence on the
left side developed 9 months later. Computed tomography
showed no pleural bulla or interstitial lung disease. Open tho-
racotomy revealed a complete regrowth of parietal pleura. A
complete pleurectomy was carried out, and she remains well
6 years after the procedure.
Patient 2
The elder brother of patient 1 presented at 17 years of age
with a small left pneumothorax that was treated with
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